FANHDI

UNIVADIS - FANHDI /univadis/FANHDI.md

ATC

Μορφές:

Ημερομηνία	barcode	code	περιεχομενο	τιμή παραγωγός	χονδρική	λιανική
05/2018	2802299201032	229920103	FANHDI PS.INJ.SOL 250 IU/VIAL BTx1VIAL+ 1PF SYR Τύπου I (σύριγγα Hypack SCF Becton-Dickinson)x10ML Τύπου I (σύριγγα Hypack SCF Becton-Dickinson)x10ML	81.07	85.04	108.17
05/2018	2802299202039	229920203	FANHDI PS.INJ.SOL 500 IU/VIAL BTx1VIAL+1PF SYR Τύπου I (σύριγγα Hypack SCF Becton-Dickinson) x10ML Τύπου I (σύριγγα Hypack SCF Becton-Dickinson) x10ML	160.76	168.63	203.77
05/2018	2802299203036	229920303	FANHDI PS.INJ.SOL 1000 IU/VIAL BTx1VIAL+1PF SYR Τύπου I (σύριγγα Hypack SCF Becton-Dickinson) x10ML Τύπου I (σύριγγα Hypack SCF Becton-Dickinson) x10ML	321.11	325.93	380.03

DRUGBANK - Antihemophilic Factor
indication:
For the treatment of hemophilia A, von Willebrand diseae and Factor XIII deficiency
pharmacology:
mechanism:
Antihemophilic factor (AHF) is a protein found in normal plasma which is necessary for clot formation. The administration of AHF provides an increase in plasma levels of AHF and can temporarily correct the coagulation defect of patients with hemophilia A (classical hemophilia).
toxicity:
absorprion:
halflife:
8.4-19.3 hrs
roouteelimination:
volumedistribution:
clearance:
* 4.1 mL/h•kg [Previously treated pediatric patients]